Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Royal Caribbean CEO says CDC, cruise industry engaged in 'constructive dialogue' » 14:25
04/19/21
04/19
14:25
04/19/21
14:25
RCL

Royal Caribbean

$84.99 /

-0.41 (-0.48%)

, CCL

Carnival

$27.10 /

+0.07 (+0.26%)

, NCLH

Norwegian Cruise Line

$28.30 /

-0.005 (-0.02%)

Richard Fain, CEO of…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RCL Royal Caribbean
$84.99 /

-0.41 (-0.48%)

CCL Carnival
$27.10 /

+0.07 (+0.26%)

NCLH Norwegian Cruise Line
$28.30 /

-0.005 (-0.02%)

RCL Royal Caribbean
$84.99 /

-0.41 (-0.48%)

03/24/21 Stifel
Cruiseline stock selloff 'unwarranted,' says Stifel
03/18/21 UBS
Royal Caribbean price target raised to $116 from $79 at UBS
03/16/21 JPMorgan
Royal Caribbean price target raised to $110 from $100 at JPMorgan
03/12/21 Truist
Royal Caribbean price target raised to $68 from $48 at Truist
CCL Carnival
$27.10 /

+0.07 (+0.26%)

04/09/21
Fly Intel: Top five analyst upgrades
04/09/21 Argus
Carnival upgraded to Buy from Hold at Argus sees 'strong' pent-up cruise demand
04/09/21 Argus
Carnival upgraded to Buy from Hold at Argus
04/09/21 Credit Suisse
Carnival upgraded to Outperform from Neutral at Credit Suisse
NCLH Norwegian Cruise Line
$28.30 /

-0.005 (-0.02%)

03/24/21 Stifel
Cruiseline stock selloff 'unwarranted,' says Stifel
03/18/21 UBS
Norwegian Cruise Line price target raised to $32 from $21 at UBS
03/16/21 JPMorgan
Norwegian Cruise Line price target raised to $36 from $33 at JPMorgan
03/12/21 Truist
Norwegian Cruise Line price target raised to $25 from $20 at Truist
RCL Royal Caribbean
$84.99 /

-0.41 (-0.48%)

CCL Carnival
$27.10 /

+0.07 (+0.26%)

NCLH Norwegian Cruise Line
$28.30 /

-0.005 (-0.02%)

  • 05
    Mar
  • 01
    Mar
  • 23
    Feb
  • 18
    Nov
  • 14
    Oct
  • 17
    Jul
  • 06
    May
RCL Royal Caribbean
$84.99 /

-0.41 (-0.48%)

CCL Carnival
$27.10 /

+0.07 (+0.26%)

NCLH Norwegian Cruise Line
$28.30 /

-0.005 (-0.02%)

RCL Royal Caribbean
$84.99 /

-0.41 (-0.48%)

CCL Carnival
$27.10 /

+0.07 (+0.26%)

NCLH Norwegian Cruise Line
$28.30 /

-0.005 (-0.02%)

RCL Royal Caribbean
$84.99 /

-0.41 (-0.48%)

CCL Carnival
$27.10 /

+0.07 (+0.26%)

NCLH Norwegian Cruise Line
$28.30 /

-0.005 (-0.02%)

Earnings
Notable companies reporting before tomorrow's open » 14:11
04/19/21
04/19
14:11
04/19/21
14:11
JNJ

Johnson & Johnson

$162.24 /

+0.09 (+0.06%)

, PG

Procter & Gamble

$136.73 /

-0.44 (-0.32%)

, ABT

Abbott

$125.24 /

+0.87 (+0.70%)

, PM

Philip Morris

$92.94 /

+0.02 (+0.02%)

, LMT

Lockheed Martin

$390.82 /

-1.02 (-0.26%)

, TRV

Travelers

$154.02 /

-1.93 (-1.24%)

, FITB

Fifth Third

$37.87 /

-0.33 (-0.86%)

, KEY

KeyCorp

$20.54 /

-0.13 (-0.63%)

, OMC

Omnicom

$79.43 /

-0.23 (-0.29%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include Johnson & Johnson (JNJ), consensus $2.34... Procter & Gamble (PG), consensus $1.19... Abbott (ABT), consensus $1.27... Philip Morris (PM), consensus $1.40... Lockheed Martin (LMT), consensus $6.30... Travelers (TRV), consensus $2.37... Fifth Third Bancorp (FITB), consensus 69c... KeyCorp (KEY), consensus 48c... Omnicom (OMC), consensus $1.13.

ShowHide Related Items >><<
JNJ Johnson & Johnson
$162.24 /

+0.09 (+0.06%)

PG Procter & Gamble
$136.73 /

-0.44 (-0.32%)

ABT Abbott
$125.24 /

+0.87 (+0.70%)

PM Philip Morris
$92.94 /

+0.02 (+0.02%)

LMT Lockheed Martin
$390.82 /

-1.02 (-0.26%)

TRV Travelers
$154.02 /

-1.93 (-1.24%)

FITB Fifth Third
$37.87 /

-0.33 (-0.86%)

KEY KeyCorp
$20.54 /

-0.13 (-0.63%)

OMC Omnicom
$79.43 /

-0.23 (-0.29%)

JNJ Johnson & Johnson
$162.24 /

+0.09 (+0.06%)

09:14 Today Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
PG Procter & Gamble
$136.73 /

-0.44 (-0.32%)

04/16/21 JPMorgan
Procter & Gamble price target lowered to $148 from $153 at JPMorgan
03/02/21 BofA
Procter & Gamble removed from the US 1 List at BofA
01/28/21 Stifel
Stifel downgrades Procter & Gamble to Hold on emerging headwinds
01/28/21 Stifel
Procter & Gamble downgraded to Hold from Buy at Stifel
ABT Abbott
$125.24 /

+0.87 (+0.70%)

04/15/21 Atlantic Equities
Atlantic Equities starts Abbott at Neutral
04/15/21 Atlantic Equities
Abbott initiated with a Neutral at Atlantic Equities
03/16/21 Piper Sandler
Abbott study challenging Abiomed's Impella halted, says Piper Sandler
03/10/21 Wells Fargo
Wells says Quidel Covid testing comments not a direct read through to Abbott
PM Philip Morris
$92.94 /

+0.02 (+0.02%)

04/09/21
Fly Intel: Top five analyst upgrades
04/09/21 JPMorgan
Philip Morris upgraded on heated tobacco position at JPMorgan
04/08/21 JPMorgan
Philip Morris upgraded to Overweight from Neutral at JPMorgan
03/16/21 Citi
Last U.S. cigarette smoker like to quit by 2050, says Citi
LMT Lockheed Martin
$390.82 /

-1.02 (-0.26%)

04/09/21 Wolfe Research
Lockheed Martin assumed with a Peer Perform at Wolfe Research
01/27/21 Credit Suisse
Lockheed Martin price target lowered to $334 from $351 at Credit Suisse
01/07/21 Baird
Lockheed Martin downgraded to Neutral from Outperform at Baird
01/07/21 Jefferies
Jefferies downgrades Aerojet Rocketdyne to Hold, sees higher bid as unlikely
TRV Travelers
$154.02 /

-1.93 (-1.24%)

04/01/21 Credit Suisse
Travelers price target raised to $153 from $142 at Credit Suisse
03/31/21 Citi
Travelers price target raised to $155 from $142 at Citi
03/24/21 Barclays
Travelers price target raised to $165 from $155 at Barclays
03/12/21 MKM Partners
Travelers price target raised to $185 from $175 at MKM Partners
FITB Fifth Third
$37.87 /

-0.33 (-0.86%)

04/09/21 Jefferies
Fifth Third price target raised to $44 from $36 at Jefferies
04/07/21 Barclays
Fifth Third price target raised to $43 from $37 at Barclays
04/01/21 Wells Fargo
Fifth Third price target raised to $36 from $28 at Wells Fargo
04/01/21 Deutsche Bank
Fifth Third price target raised to $38 from $30 at Deutsche Bank
KEY KeyCorp
$20.54 /

-0.13 (-0.63%)

09:50 Today Gordon Haskett
Jet data shows KeyCorp visited Comerica's home of Dallas, says Gordon Haskett
04/09/21 Jefferies
KeyCorp price target raised to $23 from $21 at Jefferies
04/07/21 Barclays
KeyCorp price target raised to $22 from $20 at Barclays
04/01/21 Deutsche Bank
KeyCorp price target raised to $21 from $18 at Deutsche Bank
OMC Omnicom
$79.43 /

-0.23 (-0.29%)

12/15/20 Citi
Omnicom price target raised to $75 from $60 at Citi
11/02/20 Evercore ISI
Omnicom upgraded to In Line from Underperform at Evercore ISI
10/30/20 Huber Research
Omnicom upgraded to Overweight from Underweight at Huber Research
10/28/20
Fly Intel: Top five analyst upgrades
JNJ Johnson & Johnson
$162.24 /

+0.09 (+0.06%)

PG Procter & Gamble
$136.73 /

-0.44 (-0.32%)

ABT Abbott
$125.24 /

+0.87 (+0.70%)

PM Philip Morris
$92.94 /

+0.02 (+0.02%)

LMT Lockheed Martin
$390.82 /

-1.02 (-0.26%)

TRV Travelers
$154.02 /

-1.93 (-1.24%)

FITB Fifth Third
$37.87 /

-0.33 (-0.86%)

KEY KeyCorp
$20.54 /

-0.13 (-0.63%)

OMC Omnicom
$79.43 /

-0.23 (-0.29%)

JNJ Johnson & Johnson
$162.24 /

+0.09 (+0.06%)

PG Procter & Gamble
$136.73 /

-0.44 (-0.32%)

ABT Abbott
$125.24 /

+0.87 (+0.70%)

LMT Lockheed Martin
$390.82 /

-1.02 (-0.26%)

TRV Travelers
$154.02 /

-1.93 (-1.24%)

FITB Fifth Third
$37.87 /

-0.33 (-0.86%)

KEY KeyCorp
$20.54 /

-0.13 (-0.63%)

OMC Omnicom
$79.43 /

-0.23 (-0.29%)

JNJ Johnson & Johnson
$162.24 /

+0.09 (+0.06%)

PG Procter & Gamble
$136.73 /

-0.44 (-0.32%)

ABT Abbott
$125.24 /

+0.87 (+0.70%)

PM Philip Morris
$92.94 /

+0.02 (+0.02%)

LMT Lockheed Martin
$390.82 /

-1.02 (-0.26%)

TRV Travelers
$154.02 /

-1.93 (-1.24%)

FITB Fifth Third
$37.87 /

-0.33 (-0.86%)

KEY KeyCorp
$20.54 /

-0.13 (-0.63%)

JNJ Johnson & Johnson
$162.24 /

+0.09 (+0.06%)

PG Procter & Gamble
$136.73 /

-0.44 (-0.32%)

ABT Abbott
$125.24 /

+0.87 (+0.70%)

PM Philip Morris
$92.94 /

+0.02 (+0.02%)

LMT Lockheed Martin
$390.82 /

-1.02 (-0.26%)

TRV Travelers
$154.02 /

-1.93 (-1.24%)

Periodicals
J&J affirms 100M vaccine commitment in U.S. to CNBC » 10:47
04/19/21
04/19
10:47
04/19/21
10:47
JNJ

Johnson & Johnson

$162.14 /

-0.01 (-0.01%)

, EBS

Emergent BioSolutions

$70.88 /

-6.77 (-8.72%)

Johnson & Johnson…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$162.14 /

-0.01 (-0.01%)

EBS Emergent BioSolutions
$70.88 /

-6.77 (-8.72%)

JNJ Johnson & Johnson
$162.14 /

-0.01 (-0.01%)

09:14 Today Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
EBS Emergent BioSolutions
$70.88 /

-6.77 (-8.72%)

04/07/21
Fly Intel: Top five analyst initiations
04/07/21 Benchmark
Benchmark starts Emergent at Buy, thinks shares can resume upward momentum
JNJ Johnson & Johnson
$162.14 /

-0.01 (-0.01%)

EBS Emergent BioSolutions
$70.88 /

-6.77 (-8.72%)

JNJ Johnson & Johnson
$162.14 /

-0.01 (-0.01%)

EBS Emergent BioSolutions
$70.88 /

-6.77 (-8.72%)

JNJ Johnson & Johnson
$162.14 /

-0.01 (-0.01%)

EBS Emergent BioSolutions
$70.88 /

-6.77 (-8.72%)

JNJ Johnson & Johnson
$162.14 /

-0.01 (-0.01%)

Conference/Events
American Academy of Neurology to hold a virtual meeting » 09:24
04/19/21
04/19
09:24
04/19/21
09:24
ABBV

AbbVie

$107.93 /

+1.05 (+0.98%)

, ABC

AmerisourceBergen

$119.62 /

+0.55 (+0.46%)

, ABT

Abbott

$124.37 /

+0.4 (+0.32%)

, ACAD

Acadia Pharmaceuticals

$21.17 /

-0.02 (-0.09%)

, ALNY

Alnylam

$138.69 /

-0.23 (-0.17%)

, BIIB

Biogen

$270.07 /

-0.66 (-0.24%)

, BMY

Bristol-Myers

$65.46 /

+1.02 (+1.58%)

, BHVN

Biohaven Pharmaceutical

$74.37 /

-1.435 (-1.89%)

, CPRX

Catalyst Pharmaceuticals

$4.44 /

-0.02 (-0.45%)

, DGX

Quest Diagnostics

$130.09 /

+0.86 (+0.67%)

, DNA

Bought by RHHBY

$94.97 /

+ (+0.00%)

, HZNP

Horizon Therapeutics

$93.25 /

-0.32 (-0.34%)

, LIVN

LivaNova

$81.37 /

-1.46 (-1.76%)

, LLY

Eli Lilly

$189.25 /

+3.28 (+1.76%)

, MDT

Medtronic

$125.91 /

+0.06 (+0.05%)

, NVS

Novartis

$88.02 /

+0.81 (+0.93%)

, NVTA

Invitae

$37.65 /

-1.47 (-3.76%)

, PFE

Pfizer

$38.57 /

+0.96 (+2.55%)

, PTCT

PTC Therapeutics

$48.48 /

+0.33 (+0.69%)

, RETA

Reata Pharmaceuticals

$90.83 /

-1.29 (-1.40%)

, SNY

Sanofi

$51.29 /

+0.63 (+1.24%)

, SUPN

Supernus

$31.72 /

-0.09 (-0.28%)

, TAK

Takeda Pharmaceutical

$17.08 /

-0.13 (-0.76%)

, TEVA

Teva

$10.75 /

-0.08 (-0.74%)

, TGTX

TG Therapeutics

$44.79 /

-1.05 (-2.29%)

, ZGNX

Zogenix

$19.00 /

-0.65 (-3.31%)

, AVDL

Avadel Pharmaceuticals

$8.65 /

+0.09 (+1.05%)

, JNJ

Johnson & Johnson

$162.24 /

+1.74 (+1.08%)

73rd Annual Virtual…

73rd Annual Virtual Meeting of AAN will be held on April 17-22. Webcast Link

ShowHide Related Items >><<
ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

TEVA Teva
$10.75 /

-0.08 (-0.74%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

SUPN Supernus
$31.72 /

-0.09 (-0.28%)

SNY Sanofi
$51.29 /

+0.63 (+1.24%)

RETA Reata Pharmaceuticals
$90.83 /

-1.29 (-1.40%)

PTCT PTC Therapeutics
$48.48 /

+0.33 (+0.69%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVTA Invitae
$37.65 /

-1.47 (-3.76%)

NVS Novartis
$88.02 /

+0.81 (+0.93%)

MDT Medtronic
$125.91 /

+0.06 (+0.05%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LIVN LivaNova
$81.37 /

-1.46 (-1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

CPRX Catalyst Pharmaceuticals
$4.44 /

-0.02 (-0.45%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

BHVN Biohaven Pharmaceutical
$74.37 /

-1.435 (-1.89%)

AVDL Avadel Pharmaceuticals
$8.65 /

+0.09 (+1.05%)

ALNY Alnylam
$138.69 /

-0.23 (-0.17%)

ACAD Acadia Pharmaceuticals
$21.17 /

-0.02 (-0.09%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

04/06/21 RBC Capital
AbbVie transferred with an Outperform at RBC Capital
04/01/21 Piper Sandler
Integra to benefit from FDA safety communication, says Piper Sandler
04/01/21 Piper Sandler
Piper migraine survey bearish for Amgen, bullish for Biohaven
03/17/21 JPMorgan
AbbVie selloff on Rinvoq deal 'appears overdone,' says JPMorgan
ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

03/09/21 Baird
AmerisourceBergen remains top pick following results, says Baird
02/09/21 Mizuho
AmerisourceBergen price target raised to $114 from $104 at Mizuho
02/08/21 Cowen
AmerisourceBergen price target raised to $150 from $145 at Cowen
02/04/21 Evercore ISI
AmerisourceBergen upgraded to Outperform after Q1 report at Evercore ISI
ABT Abbott
$124.37 /

+0.4 (+0.32%)

04/15/21 Atlantic Equities
Atlantic Equities starts Abbott at Neutral
04/15/21 Atlantic Equities
Abbott initiated with a Neutral at Atlantic Equities
03/16/21 Piper Sandler
Abbott study challenging Abiomed's Impella halted, says Piper Sandler
03/10/21 Wells Fargo
Wells says Quidel Covid testing comments not a direct read through to Abbott
ACAD Acadia Pharmaceuticals
$21.17 /

-0.02 (-0.09%)

04/07/21 Needham
Acadia price target lowered to $30 from $44 at Needham
04/07/21 H.C. Wainwright
Acadia downgraded to Neutral from Buy at H.C. Wainwright
04/06/21 SVB Leerink
Acadia price target lowered to $31 from $63 at SVB Leerink
04/06/21 Jefferies
Acadia downgraded to Hold at Jefferies after dementia-related psychosis CRL
ALNY Alnylam
$138.69 /

-0.23 (-0.17%)

02/22/21 Guggenheim
Alnylam downgraded to Neutral from Buy at Guggenheim
02/12/21
Fly Intel: Top five analyst downgrades
02/12/21 Barclays
Alnylam price target raised to $196 from $162 at Barclays
02/12/21 Citi
Alnylam downgraded to Neutral from Buy at Citi
BIIB Biogen
$270.07 /

-0.66 (-0.24%)

04/13/21 Roth Capital
Roth Capital sees Applied Genetic's XLRS licensing as vote of confidence
04/12/21 Oppenheimer
Sage Therapeutics data support 'enthusiasm' for SAGE-324 in ET, says Oppenheimer
04/12/21 Wedbush
Biogen price target raised to $245 from $236 at Wedbush
03/25/21 Piper Sandler
Piper says Biogen Tecfidera patents could change thesis, but sees unknowns
BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

04/13/21 Truist
Bristol-Myers upgraded to Buy at Truist on improving pipeline asset visibility
04/13/21 Truist
Bristol-Myers upgraded to Buy from Hold at Truist
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
03/08/21 BofA
Gartner added to US 1 List, Bristol-Myers removed at BofA
BHVN Biohaven Pharmaceutical
$74.37 /

-1.435 (-1.89%)

03/11/21
Fly Intel: Top five analyst initiations
03/11/21 UBS
Biohaven Pharmaceutical initiated with a Buy at UBS
03/02/21 Mizuho
Biohaven Pharmaceutical price target raised to $103 from $93 at Mizuho
CPRX Catalyst Pharmaceuticals
$4.44 /

-0.02 (-0.45%)

03/16/21 Piper Sandler
Catalyst business continues to generate cash flow, says Piper Sandler
01/07/21 Piper Sandler
Piper says Catalyst's Firdapse commercial business performing as expected
01/06/21 Piper Sandler
Catalyst Firdapse commercial business performing as expected, says Piper Sandler
11/10/20 Piper Sandler
Catalyst Pharmaceuticals price target lowered to $5.50 from $6 at Piper Sandler
DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

03/12/21 Baird
Quest Diagnostics downgraded to Neutral from Outperform at Baird
01/29/21 Citi
Quest Diagnostics price target raised to $158 from $151 at Citi
12/17/20 Morgan Stanley
Morgan Stanley cuts Quest Diagnostics to Equal Weight ahead of 2022 slowdown
12/17/20 Morgan Stanley
Quest Diagnostics downgraded to Equal Weight from Overweight at Morgan Stanley
DNA Bought by RHHBY
$94.97 /

+ (+0.00%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

03/25/21 Guggenheim
Horizon Therapeutics price target raised to $120 from $115 at Guggenheim
03/22/21
Fly Intel: Top five analyst initiations
03/22/21 Morgan Stanley
Horizon Therapeutics resumed with an Overweight at Morgan Stanley
03/18/21 Citi
Horizon Therapeutics price target raised to $120 from $116 at Citi
LIVN LivaNova
$81.37 /

-1.46 (-1.76%)

04/13/21 Piper Sandler
LivaNova price target raised to $92 from $81 at Piper Sandler
03/03/21
Fly Intel: Top five analyst downgrades
03/03/21 Berenberg
Berenberg cuts LivaNova EPS forecasts on investments, downgrades to Hold
03/03/21 Berenberg
LivaNova downgraded to Hold from Buy at Berenberg
LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

04/12/21 Benchmark
Benchmark sees full FDA approval of Regeneron's REGEN-COV coming
04/06/21 JPMorgan
JPMorgan survey 'broadly positive' on Eli Lilly Alzheimer's drug
03/24/21 BMO Capital
AbCellera price target lowered to $59 from $61 at BMO Capital
03/17/21 Mizuho
AbbVie's FDA request show Xeljanz concerns may bleed to Rinvoq, says Mizuho
MDT Medtronic
$125.91 /

+0.06 (+0.05%)

04/15/21 Atlantic Equities
Atlantic Equities starts Medtronic at Overweight
04/15/21 Atlantic Equities
Medtronic initiated with an Overweight at Atlantic Equities
04/05/21 Citi
Citi opens positive catalyst watches on four medical supply stocks
02/24/21 Cowen
Medtronic price target raised to $135 from $120 at Cowen
NVS Novartis
$88.02 /

+0.81 (+0.93%)

04/05/21 Morgan Stanley
Regenxbio AAV9 patent challenged by Passage Bio, says Morgan Stanley
03/23/21 Societe Generale
Novartis price target raised to CHF 107 from CHF 104 at Societe Generale
03/22/21 Bernstein
Novartis initiated with a Market Perform at Bernstein
03/10/21
Fly Intel: Top five analyst downgrades
NVTA Invitae
$37.65 /

-1.47 (-3.76%)

04/05/21 Oppenheimer
Oppenheimer upgrades Invitae on valuation, sees potential high $50s stock
04/05/21 Oppenheimer
Invitae upgraded to Outperform from Perform at Oppenheimer
02/18/21 Ladenburg
Invitae upgraded to Buy with $58 price target at Ladenburg
02/18/21 Ladenburg
Invitae upgraded to Buy from Neutral at Ladenburg
PFE Pfizer
$38.57 /

+0.96 (+2.55%)

04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
PTCT PTC Therapeutics
$48.48 /

+0.33 (+0.69%)

03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform at RBC Capital on valuation
03/29/21 RBC Capital
PTC Therapeutics upgraded to Sector Perform from Underperform at RBC Capital
02/26/21 Cantor Fitzgerald
PTC Therapeutics price target lowered to $75 from $81 at Cantor Fitzgerald
02/12/21 BofA
PTC Therapeutics downgraded to Neutral from Buy at BofA
RETA Reata Pharmaceuticals
$90.83 /

-1.29 (-1.40%)

11/25/20 Citi
Reata Pharmaceuticals price target lowered to $234 from $260 at Citi
11/10/20 Cantor Fitzgerald
Reata Pharmaceuticals price target raised to $220 from $169 at Cantor Fitzgerald
11/10/20 Citi
Reata Pharmaceuticals price target raised to $260 from $244 at Citi
08/11/20 Cantor Fitzgerald
Reata Pharmaceuticals price target lowered to $169 from $275 at Cantor Fitzgerald
SNY Sanofi
$51.29 /

+0.63 (+1.24%)

04/06/21 Barclays
Sanofi price target raised to EUR 85 from EUR 80 at Barclays
02/23/21 BofA
BofA adds Heineken and IAG, removes Roche and Sanofi from Europe 1 list
02/10/21 Morgan Stanley
Sanofi price target raised to EUR 104 from EUR 101 at Morgan Stanley
02/05/21 Piper Sandler
Piper reiterates Overweight on Kymera after Sanofi capital markets day
SUPN Supernus
$31.72 /

-0.09 (-0.28%)

04/13/21 Jefferies
Supernus upgraded to Buy after survey work at Jefferies
04/13/21 Jefferies
Supernus upgraded to Buy from Hold at Jefferies
02/03/21 Piper Sandler
Supernus price target raised to $35 from $30 at Piper Sandler
06/16/20 Piper Sandler
Supernus upgraded to Overweight from Neutral at Piper Sandler
TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

09:04 Today JPMorgan
Takeda Pharmaceutical downgraded to Neutral on R&D investments at JPMorgan
09:00 Today JPMorgan
Takeda Pharmaceutical downgraded to Neutral from Overweight at JPMorgan
04/15/21 Oppenheimer
Molecular Templates price target lowered to $13 from $18 at Oppenheimer
04/05/21
Fly Intel: Top five analyst downgrades
TEVA Teva
$10.75 /

-0.08 (-0.74%)

04/06/21 RBC Capital
Teva transferred with a Sector Perform at RBC Capital
01/26/21 Piper Sandler
Amarin in 'strong position' against Health Net, says Piper Sandler
12/21/20 Gabelli
Teva named 'Best Idea for 2021' at Gabelli
11/27/20 H.C. Wainwright
Corcept Therapeutics price target raised to $32 from $22 at H.C. Wainwright
TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

07:12 Today Cantor Fitzgerald
TG Therapeutics price target raised to $74 from $68 at Cantor Fitzgerald
06:14 Today H.C. Wainwright
TG Therapeutics price target raised to $89 from $79 at H.C. Wainwright
03/04/21 B. Riley
TG Therapeutics price target lowered to $91 from $95 at B. Riley Securities
02/09/21 B. Riley
TG Therapeutics price target raised to $95 from $90 at B. Riley Securities
ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

04/06/21 Evercore ISI
Evercore starts 'compelling' Arena spinoff Longboard at Outperform
04/06/21 Citi
Longboard Pharmaceuticals initiated with a Buy at Citi
02/03/21 Mizuho
Jazz deal for GW Pharma has positive read through to Zogenix, says Mizuho
12/04/20 Mizuho
Zogenix collaboration step in right direction, says Mizuho
AVDL Avadel Pharmaceuticals
$8.65 /

+0.09 (+1.05%)

03/10/21 H.C. Wainwright
Avadel Pharmaceuticals price target raised to $17 from $15 at H.C. Wainwright
01/25/21 Craig-Hallum
Avadel Pharmaceuticals assumed with a Buy rating at Craig-Hallum
08/28/20 Oppenheimer
Uwarranted pressure creates buying opportunity for Avadel, says Oppenheimer
08/28/20 SVB Leerink
Avadel selloff on Jazz competition worries overdone, says SVB Leerink
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

09:14 Today Chardan
Chardan sees J&J moving forward with Emergent if observations are minor
04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

TEVA Teva
$10.75 /

-0.08 (-0.74%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

SUPN Supernus
$31.72 /

-0.09 (-0.28%)

SNY Sanofi
$51.29 /

+0.63 (+1.24%)

RETA Reata Pharmaceuticals
$90.83 /

-1.29 (-1.40%)

PTCT PTC Therapeutics
$48.48 /

+0.33 (+0.69%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVTA Invitae
$37.65 /

-1.47 (-3.76%)

NVS Novartis
$88.02 /

+0.81 (+0.93%)

MDT Medtronic
$125.91 /

+0.06 (+0.05%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LIVN LivaNova
$81.37 /

-1.46 (-1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

CPRX Catalyst Pharmaceuticals
$4.44 /

-0.02 (-0.45%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

BHVN Biohaven Pharmaceutical
$74.37 /

-1.435 (-1.89%)

AVDL Avadel Pharmaceuticals
$8.65 /

+0.09 (+1.05%)

ALNY Alnylam
$138.69 /

-0.23 (-0.17%)

ACAD Acadia Pharmaceuticals
$21.17 /

-0.02 (-0.09%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

  • 16
    Mar
  • 22
    Jan
  • 15
    Dec
  • 02
    Dec
  • 07
    Aug
  • 15
    May
  • 29
    Apr
TEVA Teva
$10.75 /

-0.08 (-0.74%)

SNY Sanofi
$51.29 /

+0.63 (+1.24%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVS Novartis
$88.02 /

+0.81 (+0.93%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

LIVN LivaNova
$81.37 /

-1.46 (-1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

ALNY Alnylam
$138.69 /

-0.23 (-0.17%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

TEVA Teva
$10.75 /

-0.08 (-0.74%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

SUPN Supernus
$31.72 /

-0.09 (-0.28%)

SNY Sanofi
$51.29 /

+0.63 (+1.24%)

RETA Reata Pharmaceuticals
$90.83 /

-1.29 (-1.40%)

PTCT PTC Therapeutics
$48.48 /

+0.33 (+0.69%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVTA Invitae
$37.65 /

-1.47 (-3.76%)

NVS Novartis
$88.02 /

+0.81 (+0.93%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

CPRX Catalyst Pharmaceuticals
$4.44 /

-0.02 (-0.45%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

BHVN Biohaven Pharmaceutical
$74.37 /

-1.435 (-1.89%)

AVDL Avadel Pharmaceuticals
$8.65 /

+0.09 (+1.05%)

ACAD Acadia Pharmaceuticals
$21.17 /

-0.02 (-0.09%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

ZGNX Zogenix
$19.00 /

-0.65 (-3.31%)

TGTX TG Therapeutics
$44.79 /

-1.05 (-2.29%)

TEVA Teva
$10.75 /

-0.08 (-0.74%)

TAK Takeda Pharmaceutical
$17.08 /

-0.13 (-0.76%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

NVTA Invitae
$37.65 /

-1.47 (-3.76%)

MDT Medtronic
$125.91 /

+0.06 (+0.05%)

LLY Eli Lilly
$189.25 /

+3.28 (+1.76%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

HZNP Horizon Therapeutics
$93.25 /

-0.32 (-0.34%)

DGX Quest Diagnostics
$130.09 /

+0.86 (+0.67%)

BMY Bristol-Myers
$65.46 /

+1.02 (+1.58%)

BIIB Biogen
$270.07 /

-0.66 (-0.24%)

ABT Abbott
$124.37 /

+0.4 (+0.32%)

ABC AmerisourceBergen
$119.62 /

+0.55 (+0.46%)

ABBV AbbVie
$107.93 /

+1.05 (+0.98%)

Recommendations
Chardan sees J&J moving forward with Emergent if observations are minor » 09:14
04/19/21
04/19
09:14
04/19/21
09:14
EBS

Emergent BioSolutions

$77.65 /

+3.07 (+4.12%)

, JNJ

Johnson & Johnson

$162.24 /

+1.74 (+1.08%)

Chardan analyst Keay…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EBS Emergent BioSolutions
$77.65 /

+3.07 (+4.12%)

EBS Emergent BioSolutions
$77.65 /

+3.07 (+4.12%)

04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/07/21
Fly Intel: Top five analyst initiations
04/07/21 Benchmark
Benchmark starts Emergent at Buy, thinks shares can resume upward momentum
04/07/21 Benchmark
Emergent BioSolutions initiated with a Buy at Benchmark
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EBS Emergent BioSolutions
$77.65 /

+3.07 (+4.12%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EBS Emergent BioSolutions
$77.65 /

+3.07 (+4.12%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EBS Emergent BioSolutions
$77.65 /

+3.07 (+4.12%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

Hot Stocks
Emergent stops manufacturing at Baltimore facility after FDA inspection » 09:04
04/19/21
04/19
09:04
04/19/21
09:04
EBS

Emergent BioSolutions

$77.65 /

+3.07 (+4.12%)

, JNJ

Johnson & Johnson

$162.24 /

+1.74 (+1.08%)

, AZN

AstraZeneca

$50.74 /

-0.1 (-0.20%)

Emergent BioSolutions…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EBS Emergent BioSolutions
$77.65 /

+3.07 (+4.12%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

EBS Emergent BioSolutions
$77.65 /

+3.07 (+4.12%)

04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/07/21
Fly Intel: Top five analyst initiations
04/07/21 Benchmark
Benchmark starts Emergent at Buy, thinks shares can resume upward momentum
04/07/21 Benchmark
Emergent BioSolutions initiated with a Buy at Benchmark
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

04/12/21
Fly Intel: Top five analyst downgrades
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
04/12/21 Argus
AstraZeneca downgraded to Hold from Buy at Argus
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EBS Emergent BioSolutions
$77.65 /

+3.07 (+4.12%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EBS Emergent BioSolutions
$77.65 /

+3.07 (+4.12%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EBS Emergent BioSolutions
$77.65 /

+3.07 (+4.12%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

Periodicals
J&J COVID-19 vaccine paused, concerns of mistreating blood clots, WSJ reports » 06:32
04/19/21
04/19
06:32
04/19/21
06:32
JNJ

Johnson & Johnson

$162.24 /

+1.74 (+1.08%)

U.S. health authorities…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

Yesterday
Periodicals
Fauci predicts resumption of J&J COVID vaccine use, Reuters reports » 17:55
04/18/21
04/18
17:55
04/18/21
17:55
JNJ

Johnson & Johnson

$162.24 /

+1.74 (+1.08%)

Anthony Fauci on Sunday…

Anthony Fauci on Sunday predicted that U.S. health regulators will end the temporary pause on distributing Johnson & Johnson's COVID-19 vaccine, adding he expects a decision could come as soon as Friday, Reuters' Sarah Lynch reports. The U.S. Centers for Disease Control and Prevention advisory panel is set to meet on April 23 to discuss the next steps for the vaccine. Reference Link

ShowHide Related Items >><<
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

Friday
On The Fly
Fly Intel: Wall Street's top stories for Friday » 16:29
04/16/21
04/16
16:29
04/16/21
16:29
MS

Morgan Stanley

$78.58 /

-2.31 (-2.86%)

, BK

BNY Mellon

$46.05 /

-1.97 (-4.10%)

, CFG

Citizens Financial

$44.82 /

+0.15 (+0.34%)

, STT

State Street

$80.46 /

-6.07 (-7.01%)

, C

Citi

$72.46 /

-0.07 (-0.10%)

, ALXN

Alexion

$163.62 /

+6.19 (+3.93%)

, AZN

AstraZeneca

$50.74 /

-0.1 (-0.20%)

, JNJ

Johnson & Johnson

$162.24 /

+1.74 (+1.08%)

, BA

Boeing

$248.11 /

-3.09 (-1.23%)

, SQSP

Squarespace

/

+

, LSCC

Lattice Semiconductor

$57.90 /

+6.77 (+13.24%)

, PPG

PPG

$167.43 /

+13.57 (+8.82%)

, AA

Alcoa

$35.63 /

+2.765 (+8.41%)

, EDIT

Editas Medicine

$34.63 /

-6.28 (-15.35%)

, SPLK

Splunk

$134.31 /

-14.09 (-9.49%)

, MRNA

Moderna

$170.77 /

+10.95 (+6.85%)

, PFE

Pfizer

$38.57 /

+0.96 (+2.55%)

The major averages closed…

ShowHide Related Items >><<
STT State Street
$80.46 /

-6.07 (-7.01%)

SPLK Splunk
$134.31 /

-14.09 (-9.49%)

PPG PPG
$167.43 /

+13.57 (+8.82%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

MRNA Moderna
$170.77 /

+10.95 (+6.85%)

LSCC Lattice Semiconductor
$57.90 /

+6.77 (+13.24%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EDIT Editas Medicine
$34.63 /

-6.28 (-15.35%)

CFG Citizens Financial
$44.82 /

+0.15 (+0.34%)

C Citi
$72.46 /

-0.07 (-0.10%)

BK BNY Mellon
$46.05 /

-1.97 (-4.10%)

BA Boeing
$248.11 /

-3.09 (-1.23%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

ALXN Alexion
$163.62 /

+6.19 (+3.93%)

AA Alcoa
$35.63 /

+2.765 (+8.41%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

04/16/21 Wells Fargo
Wells Fargo 'expected more' from Morgan Stanley after disclosing Archegos loss
04/09/21 JMP Securities
Goldman Sachs price target raised to $400 from $338 at JMP Securities
04/07/21 Barclays
Morgan Stanley price target raised to $98 from $95 at Barclays
04/01/21 Deutsche Bank
Morgan Stanley price target raised to $79 from $68 at Deutsche Bank
BK BNY Mellon
$46.05 /

-1.97 (-4.10%)

04/09/21 Deutsche Bank
BNY Mellon price target raised to $54 from $50 at Deutsche Bank
04/07/21 Barclays
BNY Mellon price target raised to $57 from $55 at Barclays
03/26/21 JPMorgan
JPMorgan sees BNY Mellon, Wells Fargo among banks with most buyback capacity
03/24/21
Fly Intel: Top five analyst upgrades
CFG Citizens Financial
$44.82 /

+0.15 (+0.34%)

04/09/21 Jefferies
Citizens Financial price target raised to $47 from $42 at Jefferies
04/07/21 Barclays
Citizens Financial price target raised to $54 from $49 at Barclays
04/01/21 Deutsche Bank
Citizens Financial price target raised to $50 from $44 at Deutsche Bank
03/30/21 Stephens
Citizens Financial price target raised to $54 from $45 at Stephens
STT State Street
$80.46 /

-6.07 (-7.01%)

04/09/21 Deutsche Bank
State Street price target raised to $100 from $97 at Deutsche Bank
04/07/21 Barclays
State Street price target raised to $104 from $99 at Barclays
04/01/21 Wells Fargo
State Street price target raised to $90 from $83 at Wells Fargo
04/01/21 Morgan Stanley
State Street price target raised to $103 from $102 at Morgan Stanley
C Citi
$72.46 /

-0.07 (-0.10%)

04/13/21 Morgan Stanley
Citi price target raised to $89 from $81 at Morgan Stanley
04/09/21 Jefferies
Citi price target raised to $85 from $75 at Jefferies
04/07/21 Barclays
Citi price target raised to $84 from $77 at Barclays
04/05/21 Cowen
Risk to mortgage servicers rises as CFPB proposes foreclosure policy, says Cowen
ALXN Alexion
$163.62 /

+6.19 (+3.93%)

03/23/21
Fly Intel: Top five analyst downgrades
03/23/21 SVB Leerink
SVB Leerink moving to sidelines on Alexion, five others on industry concerns
03/23/21 SVB Leerink
Alexion downgraded to Market Perform from Outperform at SVB Leerink
02/04/21 Piper Sandler
Alexion downgraded to Neutral ahead of expected deal closing at Piper Sandler
AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

04/14/21 Guggenheim
Emergent BioSolutions price target lowered to $110 from $130 at Guggenheim
04/12/21
Fly Intel: Top five analyst downgrades
04/12/21 B. Riley
B. Riley calls Agenus the next Seagen, reiterates $8 target
04/12/21 Argus
AstraZeneca downgraded to Hold from Buy at Argus
JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

04/13/21 Goldman Sachs
J&J vaccine had numerical blood clot imbalance in trial, says Goldman Sachs
04/13/21 Morgan Stanley
Morgan Stanley says J&J news could improve 2022 outlook for mRNA vaccine makers
04/13/21 JPMorgan
Vaccine pause 'incremental negative' for J&J, says JPMorgan
BA Boeing
$248.11 /

-3.09 (-1.23%)

04/15/21 Credit Suisse
Boeing price target raised to $233 from $193 at Credit Suisse
04/14/21 JPMorgan
Boeing price target raised to $260 from $230 at JPMorgan
04/09/21 Baird
Baird says add to Boeing on any weakness due to 'tiny fix' needed for MAX jets
03/29/21 Goldman Sachs
Boeing resuming 787 deliveries removes overhang, says Goldman Sachs
SQSP Squarespace
/

+

LSCC Lattice Semiconductor
$57.90 /

+6.77 (+13.24%)

02/17/21 Craig-Hallum
Lattice Semiconductor price target raised to $40 from $31 at Craig-Hallum
02/17/21 KeyBanc
Lattice Semiconductor price target raised to $57 from $50 at KeyBanc
02/17/21 Cowen
Lattice Semiconductor price target raised to $56 from $48 at Cowen
02/17/21 Susquehanna
Lattice Semiconductor price target raised to $56 from $52 at Susquehanna
PPG PPG
$167.43 /

+13.57 (+8.82%)

04/15/21 Citi
Citi opens '30-day negative catalyst watch' on Axalta, PPG
04/07/21 Wells Fargo
PPG price target raised to $173 from $165 at Wells Fargo
03/15/21 Credit Suisse
PPG assumed with a Neutral at Credit Suisse
01/26/21 BofA
PPG upgraded to Buy from Neutral at BofA
AA Alcoa
$35.63 /

+2.765 (+8.41%)

04/16/21 B. Riley
Alcoa price target raised to $36 from $20 at B. Riley
04/16/21 BMO Capital
Alcoa price target raised to $38 from $36 at BMO Capital
03/24/21 Morgan Stanley
Morgan Stanley upgrades Alcoa to Overweight on better prospects for aluminum
EDIT Editas Medicine
$34.63 /

-6.28 (-15.35%)

04/16/21
Fly Intel: Top five analyst initiations
04/16/21 Goldman Sachs
Editas Medicine initiated with a Sell at Goldman Sachs
03/22/21 Credit Suisse
Editas Medicine initiated with an Outperform at Credit Suisse
03/17/21 Guggenheim
Editas Medicine assumed with a Neutral at Guggenheim
SPLK Splunk
$134.31 /

-14.09 (-9.49%)

04/16/21
Fly Intel: Top five analyst downgrades
04/16/21 KeyBanc
Splunk downgraded to Sector Weight from Overweight at KeyBanc
04/08/21 BofA
Splunk reinstated with a Buy at BofA
04/08/21 BofA
Splunk reinstated with a Buy at BofA
MRNA Moderna
$170.77 /

+10.95 (+6.85%)

04/15/21 Piper Sandler
Moderna price target raised to $234 from $208 at Piper Sandler
04/13/21 Piper Sandler
Piper reiterates $208 target on Moderna after J&J Covid vaccine pause
04/07/21 Jefferies
Catalent pact with Moderna removes potential overhang, says Jefferies
PFE Pfizer
$38.57 /

+0.96 (+2.55%)

04/09/21
Pfizer to host conference call
04/06/21 RBC Capital
Pfizer transferred with a Sector Perform at RBC Capital
STT State Street
$80.46 /

-6.07 (-7.01%)

SPLK Splunk
$134.31 /

-14.09 (-9.49%)

PPG PPG
$167.43 /

+13.57 (+8.82%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

MRNA Moderna
$170.77 /

+10.95 (+6.85%)

LSCC Lattice Semiconductor
$57.90 /

+6.77 (+13.24%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EDIT Editas Medicine
$34.63 /

-6.28 (-15.35%)

CFG Citizens Financial
$44.82 /

+0.15 (+0.34%)

C Citi
$72.46 /

-0.07 (-0.10%)

BK BNY Mellon
$46.05 /

-1.97 (-4.10%)

BA Boeing
$248.11 /

-3.09 (-1.23%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

ALXN Alexion
$163.62 /

+6.19 (+3.93%)

AA Alcoa
$35.63 /

+2.765 (+8.41%)

  • 21
    Jan
  • 24
    Jun
  • 19
    May
STT State Street
$80.46 /

-6.07 (-7.01%)

SPLK Splunk
$134.31 /

-14.09 (-9.49%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

MRNA Moderna
$170.77 /

+10.95 (+6.85%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

CFG Citizens Financial
$44.82 /

+0.15 (+0.34%)

C Citi
$72.46 /

-0.07 (-0.10%)

BK BNY Mellon
$46.05 /

-1.97 (-4.10%)

BA Boeing
$248.11 /

-3.09 (-1.23%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

AA Alcoa
$35.63 /

+2.765 (+8.41%)

STT State Street
$80.46 /

-6.07 (-7.01%)

SPLK Splunk
$134.31 /

-14.09 (-9.49%)

PPG PPG
$167.43 /

+13.57 (+8.82%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

MRNA Moderna
$170.77 /

+10.95 (+6.85%)

LSCC Lattice Semiconductor
$57.90 /

+6.77 (+13.24%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EDIT Editas Medicine
$34.63 /

-6.28 (-15.35%)

C Citi
$72.46 /

-0.07 (-0.10%)

BK BNY Mellon
$46.05 /

-1.97 (-4.10%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

ALXN Alexion
$163.62 /

+6.19 (+3.93%)

AA Alcoa
$35.63 /

+2.765 (+8.41%)

SPLK Splunk
$134.31 /

-14.09 (-9.49%)

PPG PPG
$167.43 /

+13.57 (+8.82%)

PFE Pfizer
$38.57 /

+0.96 (+2.55%)

MS Morgan Stanley
$78.58 /

-2.31 (-2.86%)

MRNA Moderna
$170.77 /

+10.95 (+6.85%)

JNJ Johnson & Johnson
$162.24 /

+1.74 (+1.08%)

EDIT Editas Medicine
$34.63 /

-6.28 (-15.35%)

CFG Citizens Financial
$44.82 /

+0.15 (+0.34%)

C Citi
$72.46 /

-0.07 (-0.10%)

BA Boeing
$248.11 /

-3.09 (-1.23%)

AZN AstraZeneca
$50.74 /

-0.1 (-0.20%)

ALXN Alexion
$163.62 /

+6.19 (+3.93%)

AA Alcoa
$35.63 /

+2.765 (+8.41%)

Hot Stocks
Carnival director Weisenburger sells $14.8M worth of shares » 14:29
04/16/21
04/16
14:29
04/16/21
14:29
CCL

Carnival

$26.95 /

-0.37 (-1.35%)

Carnival director Randall…

Carnival director Randall Weisenburger disclosed the sale of 538,762 at an average price of $27.50, for total proceeds of $14.8M. The shares were sold on April 14 and 15. Weisenburger continues to own 854,605 shares of Carnival. The stock in afternoon trading is down 1% to $27.00.

ShowHide Related Items >><<
CCL Carnival
$26.95 /

-0.37 (-1.35%)

CCL Carnival
$26.95 /

-0.37 (-1.35%)

04/09/21
Fly Intel: Top five analyst upgrades
04/09/21 Argus
Carnival upgraded to Buy from Hold at Argus sees 'strong' pent-up cruise demand
04/09/21 Argus
Carnival upgraded to Buy from Hold at Argus
04/09/21 Credit Suisse
Carnival upgraded to Outperform from Neutral at Credit Suisse
CCL Carnival
$26.95 /

-0.37 (-1.35%)

  • 23
    Feb
CCL Carnival
$26.95 /

-0.37 (-1.35%)

CCL Carnival
$26.95 /

-0.37 (-1.35%)

CCL Carnival
$26.95 /

-0.37 (-1.35%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.